Your browser doesn't support javascript.
loading
Preclinical Assessment of Enhanced Chemodynamic Therapy by an FeMnOx-Based Nanocarrier: Tumor-Microenvironment-Mediated Fenton Reaction and ROS-Induced Chemotherapeutic for Boosted Antitumor Activity.
Dirersa, Worku Batu; Kan, Tzu-Chun; Getachew, Girum; Wibrianto, Aswandi; Ochirbat, Sonjid; Rasal, Akash; Chang, Jungshan; Chang, Jia-Yaw.
Afiliación
  • Dirersa WB; Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106335, Taiwan, Republic of China.
  • Kan TC; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Getachew G; Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106335, Taiwan, Republic of China.
  • Wibrianto A; Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106335, Taiwan, Republic of China.
  • Ochirbat S; International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Rasal A; Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 106335, Taiwan, Republic of China.
  • Chang J; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Chang JY; International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
ACS Appl Mater Interfaces ; 15(48): 55258-55275, 2023 Dec 06.
Article en En | MEDLINE | ID: mdl-38013418

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Nanopartículas / Neoplasias Límite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Nanopartículas / Neoplasias Límite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2023 Tipo del documento: Article País de afiliación: China